Inhibitors for the In Vitro Assembly of Lp(a)
- 1 October 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (10) , 1774-1780
- https://doi.org/10.1161/01.atv.15.10.1774
Abstract
Lp(a) is composed of an LDL-like core and the glycoprotein apo(a). Current evidence strongly suggests that the assembly of this atherogenic lipoprotein proceeds outside the liver cells in a two-step fashion. In the first step, a loose complex is formed involving kringle-4 motifs in apo(a) and one or more Lys side chains in apoB-100. In the second step, this complex is stabilized by a disulfide bridge. Indications are that Lp(a) assembly is critical in the determination of plasma apo(a) concentrations. Therefore, we searched for substances that interfere with the first step of Lp(a) assembly. ε-Aminohexoic acid (ε-AHA), known as an inhibitor from earlier assembly studies, had an IC50 of 4.8 mmol/L. The IC50 of Pro, HO-p-aminobenzene sulfonamide, Lys, N-ε-acetyl-Lys, taurine, Glu, serotonin, and benzamidine were all >20 mmol/L. γ-Aminobutyric acid, spermine, and spermidine exhibited IC50 on the same order of magnitude as ε-AHA. The substances with the highest inhibitory action were tranexamic acid ...Keywords
This publication has 44 references indexed in Scilit:
- In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbitsEuropean Journal of Clinical Investigation, 1993
- Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an Lp(a)-like complexBiochemistry, 1993
- N‐acetylcysteine and serum concentrations of lipoprotein(a)Journal of Internal Medicine, 1991
- Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery diseaseThe American Journal of Cardiology, 1990
- Lipoprotein (a): a genetic risk factor for premature coronary heart diseaseCurrent Opinion in Lipidology, 1990
- Lipoprotein Lp(a). A risk factor for myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.Journal of Clinical Investigation, 1983
- Basis of antifibrinolytic therapyJournal of Clinical Pathology, 1980
- Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein BBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979